CytoSorbents CEO Phillip Chan said the company is preparing to enter the North American market with DrugSorb-ATR to reduce the severity of perioperative bleeding in CABG surgery due to Brilinta, ...

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...

Hyundai and Kia EVs now available with the $7,500 tax credit Tesla's Cybertruck now qualifies for the $7,500 tax credit in the US Tesla deliveries report is out: well short of yearly target ...

Institutional investors have recently bought and sold shares of the company. Dimensional Fund Advisors LP raised its stake in shares of Aytu BioPharma by 54.5% in the 2nd quarter. Dimensional Fund ...

A story of three strong women in the industry! #shorts | Fast Talk with Boy Abunda ...

We use cookies to ensure you get the best browsing experience. By continued use, you agree to our privacy policy and accept ...